Literature DB >> 25332597

Acute Myeloid Leukemia with BCR/ABL Fusion Chimera.

Manoj Madashira Gopal1, Jyoti Kotwal2, Rajan Kapoor3.   

Abstract

Philadelphia (Ph) chromosome is most commonly associated with chronic myelogenous leukemia (CML), a subset of precursor B-cell acute lymphoblastic leukemia and acute biphenotypic leukemia. In contrast only 1 % of acute myeloid leukemia (AML) show a consistent association with the Ph Chromosome. Before making a diagnosis of Ph + AML stringent criteria need to be applied in order to differentiate it from blast crisis stage of CML. It is important to identify this rare entity as patients who otherwise carry a poor prognosis with standard chemotherapy regimen, would benefit from therapy with imatinib mesylate. This article discusses the morphological, immunophenotype and clinical characteristics of a rare case of Ph + AML.

Entities:  

Keywords:  Acute; BCR/ABL; Leukemia; Myeloid; PCR

Year:  2014        PMID: 25332597      PMCID: PMC4192221          DOI: 10.1007/s12288-014-0359-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  7 in total

Review 1.  Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects.

Authors:  R Berger; S J Chen; Z Chen
Journal:  Cancer Genet Cytogenet       Date:  1990-02

2.  Philadelphia chromosome positive acute myeloid leukemia or de novo chronic myeloid leukemia-blast phase?

Authors:  Olga Frankfurt; Leonidas C Platanias
Journal:  Leuk Lymphoma       Date:  2013-01

3.  Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.

Authors:  Sergej Konoplev; C Cameron Yin; Steven M Kornblau; Hagop M Kantarjian; Marina Konopleva; Michael Andreeff; Gary Lu; Zhuang Zuo; Rajyalakshmi Luthra; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Leuk Lymphoma       Date:  2012-07-09

4.  Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features.

Authors:  A Cuneo; A Ferrant; J L Michaux; H Demuynck; M Boogaerts; A Louwagie; C Doyen; M Stul; J J Cassiman; P Dal Cin; G Castoldi; H Van den Berghe
Journal:  Haematologica       Date:  1996 Sep-Oct       Impact factor: 9.941

5.  Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice.

Authors:  Manuel Salto-Tellez; Suresh G Shelat; Bernice Benoit; Hanna Rennert; Martin Carroll; Debra G B Leonard; Peter Nowell; Adam Bagg
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

6.  Philadelphia chromosome-positive acute myeloid leukemia (Ph + AML) treated with imatinib mesylate (IM): a report with IM plasma concentration and bcr-abl transcripts.

Authors:  Toshinori Kondo; Taizo Tasaka; Fuminori Sano; Kimiko Matsuda; Yasutaka Kubo; Yoshiko Matsuhashi; Hidekazu Nakanishi; Yoshito Sadahira; Hideho Wada; Takashi Sugihara; Kaoru Tohyama
Journal:  Leuk Res       Date:  2009-04-16       Impact factor: 3.156

7.  Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.

Authors:  Chad P Soupir; Jo-Anne Vergilio; Paola Dal Cin; Alona Muzikansky; Hagop Kantarjian; Dan Jones; Robert P Hasserjian
Journal:  Am J Clin Pathol       Date:  2007-04       Impact factor: 2.493

  7 in total
  1 in total

Review 1.  Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.

Authors:  Kodappully S Siveen; Kirti S Prabhu; Iman W Achkar; Shilpa Kuttikrishnan; Sunitha Shyam; Abdul Q Khan; Maysaloun Merhi; Said Dermime; Shahab Uddin
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.